Swiss pharma group Roche reported an increase in their global sales in the first half of the year by 5 percent, at a constant exchange rate, reaching CHF 22.9 billion due to the increased demand for cancer and autoimmune drugs, reports a press relese. According to Severin Schwan, Roche CEO, the good results are due to the performance of the cancer drugs, especially those against breast cancer, and the diagnostic division. The R&D division reported major progress as well both in Pharma and Diagnostic areas. )…) Considering the performance of Roche Group over the first six months, I am sure we will meet our targets for 2014,” stressed Schwan. For the current year, Roche forecasts an increase in sales of about 5 percent, for a constant exchange rate and higher dividends.
Elena Udrea launches unprecedented attacks against SRI leadership: The panic after I accused a SRI General shows the fear of those who have skeletons in their closets
Geoana, Vanghelie launch Initiative Group for the New Social Democrat Project, say Ponta’s political sultanate will end soon
President Iohannis visits the 33rd Mountain Troops Battalion “Posada”, takes lunch with the soldiers
Prime Minister reiterates: Current parliamentary majority is solid, the Liberals’ censure motion has no chance
UNPR’s Oprea: We fully support Victor Ponta as Prime Minister, we don’t knock down governments we are part of
The Nine O’Clock Supplement
Nine O’Clock Announcements
5, Intrarea Armasului, District 1, Bucharest, Telephone: 317.71.36 / 317.71.35, Fax: 317.71.33 / 317.71.39
Nine O`clock Ads
Subscribe to RSS
Subscribe to RSS or enter you email to receive newsletter for news, articles, and updates about what's new.